Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials-Reference-Cited by-同舟云学术

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials

Published:2013-03-20 Issue:8 Volume:15 Page:737-749
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Wang B.,Zhong J.¹,Lin H.²,Zhao Z.¹,Yan Z.¹,He H.¹,Ni Y.¹,Liu D.¹,Zhu Z.¹

Affiliation:

1. Center for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital; Third Military Medical University; Chongqing; China

2. Department of Military Epidemiology, College of Military Preventive Medicine; Third Military Medical University; Chongqing; China

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12085/fullpdf

Reference77 articles.

1. Treatment and control of blood pressure in patients with diabetes mellitus;Choe;Am J Health Syst Pharm,2007

2. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study;Jurado;J Am Acad Nurse Pract,2009

3. Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study;Jones;Curr Med Res Opin,2009

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Group;Lancet,1998

5. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial;Patel;Lancet,2007

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasal turbinate lymphatic obstruction: a proposed new paradigm in the etiology of essential hypertension;Frontiers in Medicine;2024-08-16

2. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group;Diabetes Therapy;2024-07-11

3. Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? Insights from post-hoc analysis of EXSCEL;Diabetes Research and Clinical Practice;2024-06

4. Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis;Frontiers in Endocrinology;2024-05-31

5. Semaglutide in Cardiometabolic Diseases: SELECTing the Target Population;Journal of Cardiovascular Development and Disease;2024-05-07